You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 23, 2025

Details for Patent: 7,910,608


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,910,608 protect, and when does it expire?

Patent 7,910,608 protects YUPELRI and is included in one NDA.

This patent has thirty-eight patent family members in twenty-seven countries.

Summary for Patent: 7,910,608
Title:Biphenyl compounds useful as muscarinic receptor antagonists
Abstract: This invention provides compounds of formula I: ##STR00001## wherein a, b, c, d, m, n, p, s, t, W, Ar.sup.1, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.6, R.sup.7, and R.sup.8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
Inventor(s): Mammen; Mathai (Redwood Shores, CA), Ji; Yu-Hua (Redwood City, CA), Mu; YongQi (Los Altos, CA), Husfeld; Craig (Redwood City, CA), Li; Li (Sunnyvale, CA)
Assignee: Theravance, Inc. (South San Francisco, CA)
Application Number:11/879,835
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,910,608

Introduction

United States Patent 7,910,608, titled "Biphenyl compounds useful as muscarinic receptor antagonists," is a patent that protects specific chemical compounds and their uses. To understand the patent's scope and claims, it is essential to delve into its various components, including the claim language, prior art, and the broader patent landscape.

Patent Overview

Publication Details

  • Publication Number: US7910608B2
  • Authority: United States
  • Prior Art Date: The patent was filed on July 17, 2007, and granted on June 22, 2010[4].

Invention Description

The patent describes biphenyl compounds that act as muscarinic receptor antagonists. These compounds are designed to inhibit the action of muscarinic receptors, which are involved in various physiological processes. The invention includes the chemical structures of these compounds, their synthesis methods, and their pharmaceutical compositions[4].

Claim Scope and Structure

Importance of Claim Scope

The scope of patent claims is crucial as it defines the boundaries of the invention and the protection it receives. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate[5].

Claim Analysis

  • Independent Claims: The patent includes several independent claims that define the scope of the invention. These claims specify the chemical structures of the biphenyl compounds and their uses as muscarinic receptor antagonists.
  • Dependent Claims: Dependent claims further narrow down the scope by adding additional limitations to the independent claims. These claims often specify particular aspects of the compounds, such as specific substituents or pharmaceutical compositions.

Metrics for Measuring Claim Scope

Research suggests that the scope of patent claims can be measured using metrics such as independent claim length and independent claim count. Narrower claims, as measured by these metrics, are associated with a higher probability of grant and a shorter examination process[3].

Prior Art and Patent Landscape

Prior Art Search

To ensure the novelty and non-obviousness of the invention, a thorough prior art search is essential. For US Patent 7,910,608, this would involve searching databases such as the USPTO's Patent Public Search, European Patent Office's esp@cenet, and other international patent databases[1].

Global Dossier and Common Citation Document

Tools like the Global Dossier and Common Citation Document (CCD) can provide insights into the patent family and prior art citations from multiple IP offices. This helps in understanding the global patent landscape and identifying potential prior art that could affect the validity of the patent[1].

Examination Process and Claim Narrowing

Patent Examination Data System (PEDS)

The PEDS system allows public users to search and download bibliographic data for patent applications, providing insights into the examination process. Studies have shown that the examination process often narrows the scope of patent claims, making them more specific and less broad[3].

Impact on Patent Quality

The narrowing of claims during the examination process can improve patent quality by reducing the likelihood of overly broad claims that might be invalidated. This process ensures that the claims are well-defined and aligned with the disclosed embodiments[5].

Risks of Overly Broad Claims

Abstract Idea Exception

Overly broad claims can run afoul of the abstract idea exception, as seen in court decisions like Yu v. Apple Inc.. This exception can lead to the invalidation of claims that are deemed too abstract or not sufficiently tied to the specific embodiments disclosed in the patent specification[5].

Written Description Requirement

Another risk is the failure to meet the written description requirement. Claims must be anchored to the embodiments described in the specification to avoid invalidation. This ensures that the claims are supported by the disclosure and are not overly broad[5].

Practical Considerations

Budget and Technical Field

The claim scope must be balanced with factors such as the client’s budget and the level of prior art in the technical field. In fields with extensive prior art, broader claims are more difficult to get allowed and can be more costly to prosecute[5].

International Patent Landscape

Searchable Databases

To see if similar inventions have been patented abroad, one must refer to searchable databases provided by international intellectual property offices such as the European Patent Office, Japan Patent Office, and the World Intellectual Property Organization (WIPO)[1].

Key Takeaways

  • Claim Scope: The scope of patent claims is critical and must be balanced between breadth and specificity.
  • Prior Art Search: Thorough prior art searches are essential to ensure the novelty and non-obviousness of the invention.
  • Examination Process: The patent examination process often narrows the scope of claims, improving patent quality.
  • Risks of Broad Claims: Overly broad claims can be invalidated due to the abstract idea exception or failure to meet the written description requirement.
  • International Landscape: Understanding the global patent landscape through tools like Global Dossier and CCD is vital.

FAQs

Q: What is the importance of claim scope in a patent application?

A: The claim scope defines the boundaries of the invention and the protection it receives. It must be balanced between breadth and specificity to avoid invalidation and ensure grant.

Q: How can the scope of patent claims be measured?

A: Metrics such as independent claim length and independent claim count can be used to measure the scope of patent claims. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Q: What are the risks of having overly broad claims in a patent?

A: Overly broad claims can be invalidated due to the abstract idea exception or failure to meet the written description requirement. They are also more difficult to get granted and can be more costly to prosecute[5].

Q: How does the patent examination process affect the scope of claims?

A: The examination process often narrows the scope of claims, making them more specific and less broad. This improves patent quality by reducing the likelihood of overly broad claims[3].

Q: What tools can be used to search for prior art in patent applications?

A: Tools such as the USPTO's Patent Public Search, Global Dossier, Common Citation Document (CCD), and international patent databases like esp@cenet and PATENTSCOPE can be used to search for prior art[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Unified Patents Portal - MY-144482-A: https://portal.unifiedpatents.com/patents/patent/MY-144482-A
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Google Patents - US7910608B2: https://patents.google.com/patent/US7910608B2/en
  5. Rimon Law - The Importance of Getting the Claim Scope Right in a US Patent Application: https://www.rimonlaw.com/the-importance-of-getting-the-claim-scope-right-in-a-us-patent-application-i/

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,910,608

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Mylan Ireland Ltd YUPELRI revefenacin SOLUTION;INHALATION 210598-001 Nov 9, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 7,910,608

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 048032 ⤷  Try for Free
Argentina 104444 ⤷  Try for Free
Austria E395335 ⤷  Try for Free
Austria E467617 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.